EMAIL THIS PAGE TO A FRIEND

Presse medicale (Paris, France : 1983)

[Drug treatment for hypertrophic cardiomyopathy].


PMID 19446431

Abstract

Drug treatment of hypertrophic cardiomyopathy is the first-line treatment, at the onset of clinical signs and symptoms. Beta-blockers are proposed for symptomatic patients with no gradient or with a gradient that appears only on exertion. Verapamil is the standard second-line drug,when the beta-blockers are insufficient or ineffective but must be avoided when there is blockage at rest with severe symptoms. Disopyramide is indicated for patients with obstruction who do not respond to beta blockers and/or verapamil. Treatment with anticoagulants is widely prescribed because this disease is highly emboligenic.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

D6035 Disopyramide phosphate salt
C21H29N3O · H3O4P